Skip to content

Delivering a lung cancer screening pathway co-designed with Maori Providers

Enhancing lung cancer screening delivery to Maori communities – the role of Maori Providers

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000144314
Enrollment
400
Registered
2026-02-04
Start date
2026-02-16
Completion date
2026-12-31
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Enhancing lung cancer screening delivery to Maori communities - the role of Maori providers. This is a mixed (quantitative and qualitative) methods prospective cohort study that invites eligible participants to undergo the lung cancer screening pathway including, if eligible, a low dose CT to screen for lung cancer. The study includes an assessment of the effectiveness of Maori Provider led invitation, and also assessments of participant and staff experience. The study will contribute to the development of a national strategy for equitable lung cancer screening in New Zealand.

Interventions

This is a mixed (quantitative and qualitative) methods prospective cohort study including people offered lung cancer screening and an evaluation of participant/whanau and Maori Provider staff experience. Participants are invited by participating Maori Providers either opportunistically at an appointment for another reason, or at a community event, or after a systematic search of Provider records and a mail out or telephone contact. Their eligibility is checked via a search of their medical recor

This is a mixed (quantitative and qualitative) methods prospective cohort study including people offered lung cancer screening and an evaluation of participant/whanau and Maori Provider staff experience. Participants are invited by participating Maori Providers either opportunistically at an appointment for another reason, or at a community event, or after a systematic search of Provider records and a mail out or telephone contact. Their eligibility is checked via a search of their medical records, with consent. The participants undergo a verbal risk assessment, either face to face or over the telephone. The assessment uses the PLCOm2020 risk assessment tool. This conversation and assessment usually takes between 1o and 20 minutes. It is followed, if the participant is eligible, by a single low dose CT scan, delivered by a qualified CT technician at Canopy Cancer Care, Palmerston North. The scan would usually be within a week or two of the risk assessment, and is arranged at a time to suit the participant. The scan appointment usually takes around 15 minutes. All participant interactions are logged in a bespoke IT system for the study, which will be reviewed regularly by the study project manager.

Sponsors

University of Otago
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
50 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

Maori aged 50-74 years, domiciled in the MidCentral Health NZ / Te Whatu Ora District, current or ex-smokers, including those who are not currently enrolled with a GP, who do not meet any exclusion criteria

Exclusion criteria

Never smokers, those with clinical symptoms suspicious for lung cancer, previous diagnosis of lung cancer, have received chemotherapy or cytotoxic drugs within the last six months, and pregnancy; unable to provide informed consent due to cognitive problems; unwilling to provide consent.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 15, 2026